COVID-19 Case Rollover Tentative; Next Week’s Data = Critical

Equities faced some new headwinds this week. (i) Vaccine supply in the US is being questioned, as the White House passed on buying more Pfizer doses (but US has ordered 700 million doses), (ii) the stimulus relief package seems stuck in the Washington quagmire (iii) The Federal trade commission and multiple state attorney generals brought anti-trust charges to Facebook and (iv) there is a natural questions of whether the AirBnB and Doordash IPOs created a lot of new supply.

And if these were...

Finish reading this report for free

Enter your email and we’ll send the paywall-free link directly to your inbox

In addition to your unlocked report, you will receive our weekly market newsletter FSI Snapshot, as well as occasional updates and offers from FS Insight. You can unsubscribe at any time. For more information, see our privacy policy.

Get unlimited access to Tom Lee’s Fundstrat research Subscribe
Already a member? Log in

More from the author

Disclosures (show)

Sign in to read the report!

We’ve detected that you have an active subscription!

Ray: 948831-6eabfc-f25f7e-1e2393-ca668c

Events

Trending tickers in our research